Subtopic Deep Dive
Prognostic Factors in Cutaneous T-Cell Lymphomas
Research Guide
What is Prognostic Factors in Cutaneous T-Cell Lymphomas?
Prognostic factors in cutaneous T-cell lymphomas are clinical, histologic, and molecular predictors of survival validated through multivariate analyses in mycosis fungoides, Sézary syndrome, and related subtypes.
Research identifies staging, blood involvement, and large-cell transformation as key predictors in mycosis fungoides/Sézary syndrome (Agar et al., 2010, 823 citations). EORTC studies define prognostic factors for subcutaneous panniculitis-like T-cell lymphoma distinguishing α/β from γ/δ subtypes (Willemze et al., 2007, 686 citations). Over 10 major papers from 2003-2019 establish classification-based risk stratification (Willemze, 2005, 3766 citations).
Why It Matters
Prognostic models from Agar et al. (2010) validate ISCL/EORTC staging to stratify mycosis fungoides/Sézary syndrome patients for trials, predicting 5-year survival from 97% in early stages to 40% in advanced disease. Willemze et al. (2007) identified 83 subcutaneous panniculitis-like T-cell lymphoma cases where α/β subtype shows 82% 5-year survival versus aggressive γ/δ behavior, guiding targeted therapies. Gallamini (2003) developed a model for peripheral T-cell lymphomas using age, performance status, and LDH, applied in cutaneous variants for counseling on disease trajectory (597 citations). These factors inform clinical decisions in dermatology-oncology clinics managing 6-13% of cutaneous lymphomas.
Key Research Challenges
Heterogeneous Patient Cohorts
Multivariate analyses struggle with variable staging across mycosis fungoides and Sézary syndrome cases (Agar et al., 2010). Validation requires large cohorts lacking in rare subtypes like subcutaneous panniculitis-like T-cell lymphoma (Willemze et al., 2007).
Molecular Biomarker Validation
T-cell receptor clonality and blood involvement need prospective validation beyond retrospective EORTC data (Willemze et al., 2005). Distinguishing prognostic α/β from γ/δ T-cells demands standardized assays (Willemze et al., 2007).
Integration with Classifications
Updated WHO-EORTC schemes alter prognostic groupings, complicating comparisons across studies (Willemze et al., 2019, 1301 citations). Models like Gallamini's for PTCL-U require adaptation to cutaneous-specific factors (Gallamini, 2003).
Essential Papers
WHO-EORTC classification for cutaneous lymphomas
Rein Willemze · 2005 · Blood · 3.8K citations
Primary cutaneous lymphomas are currently classified by the European Organization for Research and Treatment of Cancer (EORTC) classification or the World Health Organization (WHO) classification, ...
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Rein Willemze, Lorenzo Cerroni, Werner Kempf et al. · 2019 · Blood · 1.3K citations
Abstract Primary cutaneous lymphomas are a heterogeneous group of T- and B-cell lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. The 2005 Worl...
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · 2012 · Journal of Clinical Oncology · 976 citations
Purpose Systemic anaplastic large-cell lymphoma (ALCL) is an aggressive subtype of T-cell lymphoma characterized by the uniform expression of CD30. The antibody-drug conjugate brentuximab vedotin d...
ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage, Nancy L. Harris, Julie M. Vose et al. · 2008 · Blood · 845 citations
Abstract The International Peripheral T-Cell Lymphoma Project is a collaborative effort designed to gain better understanding of peripheral T-cell and natural killer (NK)/T-cell lymphomas (PTCLs). ...
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Nita Agar, Emma Wedgeworth, Siobhan Crichton et al. · 2010 · Journal of Clinical Oncology · 823 citations
Purpose We have analyzed the outcome of mycosis fungoides (MF) and Sézary syndrome (SS) patients using the recent International Society for Cutaneous Lymphomas (ISCL)/European Organisation for Rese...
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases
Rein Willemze, Patty M. Jansen, Lorenzo Cerroni et al. · 2007 · Blood · 686 citations
In the WHO classification, subcutaneous panniculitis-like T-cell lymphoma (SPTL) is defined as a distinct type of T-cell lymphoma with an aggressive clinical behavior. Recent studies suggest that d...
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
Andrea Gallamini · 2003 · Blood · 597 citations
To assess the prognosis of peripheral T-cell lymphoma unspecified, we retrospectively analyzed 385 cases fulfilling the criteria defined by the World Health Organization classification. Factors ass...
Reading Guide
Foundational Papers
Read Willemze (2005, 3766 citations) first for WHO-EORTC classification framework underpinning all prognostic studies. Follow with Agar et al. (2010, 823 citations) validating staging in mycosis fungoides/Sézary cohorts. Willemze et al. (2007, 686 citations) for subcutaneous subtype specifics.
Recent Advances
Willemze et al. (2019, 1301 citations) updates classification impacting prognosis. Trautinger et al. (2017, 444 citations) provides EORTC treatment guidelines tied to risk stratification.
Core Methods
Multivariate Cox proportional hazards models (Agar et al., 2010). Kaplan-Meier survival estimation by ISCL/EORTC stages. Retrospective cohort analyses with immunophenotyping (Willemze et al., 2007).
How PapersFlow Helps You Research Prognostic Factors in Cutaneous T-Cell Lymphomas
Discover & Search
Research Agent uses searchPapers('prognostic factors cutaneous T-cell lymphoma OR mycosis fungoides survival') to retrieve 50+ papers including Agar et al. (2010), then citationGraph reveals Willemze (2005, 3766 citations) as hub with 100+ forward citations on staging. findSimilarPapers on Willemze et al. (2007) surfaces 20 EORTC studies on subcutaneous subtypes; exaSearch drills into 'α/β vs γ/δ prognosis' for obscure validations.
Analyze & Verify
Analysis Agent applies readPaperContent to extract survival curves from Agar et al. (2010), then runPythonAnalysis with pandas fits Kaplan-Meier models and computes hazard ratios from provided data tables. verifyResponse (CoVe) cross-checks claims against Willemze et al. (2019) full text, achieving GRADE B evidence for staging proposals via statistical verification of p-values <0.001.
Synthesize & Write
Synthesis Agent detects gaps like missing γ/δ subtype trials post-Willemze (2007), flags contradictions between PTCL-U models (Gallamini, 2003) and cutaneous data. Writing Agent uses latexEditText to draft staging tables, latexSyncCitations integrates 15 refs, latexCompile produces review PDF; exportMermaid generates prognostic factor flowcharts from EORTC classifications.
Use Cases
"Extract survival data from Agar 2010 mycosis fungoides paper and plot Kaplan-Meier curves by stage"
Research Agent → searchPapers → readPaperContent (Agar et al.) → Analysis Agent → runPythonAnalysis (pandas survival curves, matplotlib plot) → researcher gets CSV of hazard ratios and overlaid KM plots.
"Write LaTeX section on Willemze 2007 prognostic factors for subcutaneous T-cell lymphoma with citations"
Research Agent → citationGraph (Willemze 2007) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (10 refs) + latexCompile → researcher gets formatted PDF section with table of 5-year survivals.
"Find GitHub repos analyzing cutaneous lymphoma prognostic datasets"
Research Agent → searchPapers('cutaneous T-cell lymphoma prognosis dataset') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets 3 repos with R scripts for multivariate Cox models on SEER data.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'cutaneous T-cell lymphoma prognosis', structures report with survival meta-analysis from Agar (2010) and Willemze (2007), outputs GRADE-graded table. DeepScan's 7-steps verify EORTC staging revisions (Willemze 2019) with CoVe checkpoints against 2005 baseline. Theorizer generates hypotheses linking Gallamini (2003) PTCL model to cutaneous blood involvement for novel risk scores.
Frequently Asked Questions
What defines prognostic factors in cutaneous T-cell lymphomas?
Clinical staging, blood tumor burden, and histologic transformation predict survival in mycosis fungoides/Sézary syndrome (Agar et al., 2010). EORTC studies highlight α/β T-cell clonality in subcutaneous subtypes (Willemze et al., 2007).
What methods identify these prognostic factors?
Multivariate Cox regression on ISCL/EORTC staging cohorts (Agar et al., 2010). Retrospective analysis of 83 cases distinguishes aggressive γ/δ from indolent α/β panniculitis-like lymphomas (Willemze et al., 2007).
What are key papers on this topic?
Agar et al. (2010, 823 citations) validates staging in mycosis fungoides (JCO). Willemze et al. (2007, 686 citations) defines panniculitis-like prognosis (Blood). Willemze (2005, 3766 citations) establishes WHO-EORTC classification baseline.
What open problems remain?
Prospective validation of molecular markers like TCR clonality across subtypes. Integration of 2018 WHO-EORTC updates into survival models (Willemze et al., 2019). Adaptation of systemic PTCL scores to cutaneous variants (Gallamini, 2003).
Research Cutaneous lymphoproliferative disorders research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Prognostic Factors in Cutaneous T-Cell Lymphomas with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers